MAPT and tauopathy: Despite the diversity in posttranslational modifications, a cohort of neurodegenerative tauopathies share the trait of the deposition of hyperphosphorylated tau, whether wildtype or bearing a mutation [5,6], suggesting that abnormal phosphorylation of tau plays one of the key factors in the disease.